Hepatitis
From the Journals
Hep C, HIV coinfection tied to higher MI risk with age
“Clinicians providing health care to people with HIV should know their patients’ HCV status and provide support regarding HCV treatment and ways...
News
Few hepatitis C patients receive timely treatment: CDC
More people need to connect to treatments and disparities of access must be reduced.
From the Journals
HCV reinfection uncommon among people who inject drugs
In a new study, most reinfections occurred within 24 weeks of completing treatment.
From the Journals
Liver cancer risk persists after direct-acting antiviral treatment for HCV
“Even with that decline in risk up to 7 years after eradication of hepatitis C with direct-acting antivirals, the risk is still high enough to...
Latest News
Link between pediatric hepatitis and adenovirus 41 still unclear
Although there is a high adenovirus positivity rate amongst these cases, there is not enough evidence yet to say adenovirus 41 is a new cause of...
From the Journals
High residual liver cancer risk in HCV-cured cirrhosis
The predicted probability of HCC in cirrhosis patients was 410 times greater than the general population.
From the Journals
Liver disease and death rates fall after hepatitis C treatment barriers are dismantled
Uptake is uneven, and more needs to be done to facilitate treatment.
From the Journals
Bulevirtide reduces hepatitis D viral load in difficult-to-treat patients
Bulevirtide led to a significant viral response in 78% of patients by week 48.
Conference Coverage
Finding HBV ‘cure’ may mean going ‘back to the drawing board’
Development of new HBV drugs looks more complicated than initially expected, and it’s time to refine and refocus goals, according to one...
Conference Coverage
Phase 3 data shows bulevirtide benefit in hepatitis D
“For us in the hepatitis D field, it is a really exciting time; it’s completely novel data and game-changing for patients.”
Latest News
Acute hepatitis cases in children show declining trend; adenovirus, COVID-19 remain key leads
Adenovirus remains the most commonly detected virus in acute hepatitis in children, found in 53% of cases overall.